Finding cures. Saving children.® 2015 St. Jude Annual Report|
St. Jude Patient
Trippacute myeloid leukemia
2Meet Sebastian
Our Mission
4
A Great Hospital 6
A Great Research Institution 12
A Great Charity 22
Leadership & Service 30
Financials 40
St. Jude Children’s Research Hospital® is leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases.
Our purpose is clear: Finding cures. Saving children.
®
Finding cures. Saving children.® 2015 St. Jude Annual Report | Page 2
Meet Sebastian age 8 medulloblastoma
Sebastian was always a happy, active boy. Nothing prepared his family for the day in June 2014 when they learned he suffered from a rare brain cancer called medulloblastoma.
“We were devastated,” said his mother, Belen.
Sebastian’s doctor sent his family to St. Jude Children’s Research Hospital for his care. Sebastian’s treatment at St. Jude included chemotherapy and radiation therapy. He recently finished t eatment and now visits St. Jude every three months for scans.
“Ther e are no words to describe St. Jude,” Belen said. “Everything is designed so the fami ly only worries about loving their child. We’re grateful there is a place like St. Jude.”
|
St. Jude Patient
Bentonacute lymphoblastic leukemia
Finding cures. Saving children.® 2015 St. Jude Annual Report | Page 4
Our Mission The mission of St. Jude Children’s Research Hospital is to advance cures, and means of prevention, for pediatric catastrophic diseases through research and treatment. Consistent with the vision of our founder, Danny Thomas, no child is denied treatment based on race, religion or a family’s ability to pay.
ALSAC is the fundraising and awareness organization for St. Jude. ALSAC’s sole mission is to raise the funds and awareness necessary to operate and maintain St. Jude.
For more information, please visit stjude.org.
St. Jude Patient
Brycesickle cell disease
Finding cures. Saving children.® 2015 St. Jude Annual Report | Page 6
A Great Children’s HospitalEveryone at St. Jude is committed to providing the absolute best in patient care to the children who walk through our doors.
We put every child and their family at the center of our efforts to fight the diseases that th eaten young lives. Even before a family arrives at the hospital, a dedicated team is preparing to not only treat their child, but also to support them during one of the toughest times that families ever face.As innovators in patient care, we are by their side at every step, through every decision, providing a seamless network of support for our patients and their families. And the cost of this exceptional care is never a burden: No family ever receives a bill from St. Jude for treatment, travel, housing or food – because we believe all a family should worry about is helping their child live.
St. Jude Patient
Addisionglioma
St. Jude Patient
JuliaWilms tumor
We want the kids of St. Jude to thrive – even while undergoing treatment. They are not just a patient. They are children and teens with hopes and dreams and wishes, and so we celebrate their lives and milestones every day. We cheer them on as they master new school work, walk the red carpet at the St. Jude Teen Formal and dress up to go trick-or-treating throughout the hospital at Halloween.
We don’t stop there. We follow our patients’ progress after treatment ends, through the largest long-term follow-up clinic for childhood cancer patients in the country. We care about how their treatment affects their lives as adults, and so we are leading one of the country’s most ambitious studies of childhood cancer survivors.
We are committed to providing the very best patient care – because we want the very best for the kids of St. Jude.
St. Jude treats patients from
all50 states& around the world
Treatments invented at St. Jude have helped push the %
overall childhood survival rate from
201962
80%tomorethan
today
Meet Liam age 3 | ATRT
Three-year-old Liam is in some ways a typical little man, says his mom. “He likes to watch TV and eat popcorn.” But in other ways, Liam is anything but typical. In 2014, a very large mass was found in the left frontal lobe of his brain. It proved to be ATRT, a rare and aggressive form of cancer.
Two days after the tumor was discovered, Liam underwent his first brain surgery in his home state of Ohio. Devastated and numb, Liam’s family didn’t know what to do next, until his mom spoke with the father of another little child with ATRT who had been finished with t eatment a year and was still cancer-free. That child had been treated at St. Jude Children’s Research Hospital. “After I got off the phone with him, for the first time, I felt hopeful,” said Liam s mom.
At St. Jude, Liam’s treatment included additional surgery, chemotherapy and proton beam therapy. Liam is now finished with t eatment and returns to St. Jude regularly for checkups.
“ Because we haven’t had to worry about housing or medical costs,” said his mom, “we’ve been able to all be together as a family. It opens your eyes to how even though bad things can happen, there’s still things to be grateful for.”
Finding cures. Saving children.® 2015 St. Jude Annual Report | Page 10
Finding cures. Saving children.® 2015 St. Jude Annual Report | Page 12
A Great Research InstitutionWhen St. Jude opened in 1962, cancer was a virtual death sentence for children – only 20% survived.
In the case of acute lymphoblastic leukemia, the most common form of childhood cancer, the survival rate was a grim 4%. St. Jude tackled those somber statistics head on and forever changed the fates of children diagnosed with cancer.
Today, treatments invented at St. Jude have helped push the overall survival rate to more than 80% and, at St. Jude, the survival rate for acute lymphoblastic leukemia is now 94%, the highest in the nation.
We won’t stop until no child dies from cancer.We are working at the leading edge of science to discover better ways to diagnose and treat childhood cancer and other life-threatening diseases such as sickle cell disease. At St. Jude, we seek both cures and ways to prevent these diseases.
And we freely share our discoveries so that doctors and scientists around the world can use this knowledge to save thousands more children.
es. Saving children.® 2015 St. Jude Annual Report | Page 14Finding cur
FY15 ResearchHighlights
Genomic analysis reveals that high-risk leukemia subtype becomes more common with age
A study led by St. Jude offers vital information about a high-risk subtype of the most common childhood cancer – acute lymphoblastic leukemia (ALL). Patients with the subtype - called Ph-like ALL - are less likely to survive. The report shows that becomes more common with age, but may respond well to drugs used to treat leukemia in adults.
September 2014 | New England Journal of Medicine
Gene sequencing projects link two mutations to Ewing sarcoma subtype with poor prognosis
An international collaboration has identified a subtype of Ewing sarcoma linked to low survival rates. The study was conducted by the St. Jude Children’s Research Hospital-Washington University Pediatric Cancer Genome Project and the Institut Curie-Inserm of France. The finding lays the groundwork for more effective diagnosis and treatment of the bone and soft tissue tumor.
November 2014 | Cancer Discovery
Our laboratories may not be in every community, but our discoveries are.
Good news for young patients with a leukemia subtype associated with a poor prognosis
A study from St. Jude offers hope for children with a subtype of leukemia known for poor survival rates. The study shows that adjusting treatment based on early response to chemotherapy can make a lifesaving difference to young patients with this type of disease.
September 2014 Journal of Clinical Oncology |
Avian influenza virus isolated in harbor seals poses a threat to humans
Avian influenza is a worldwide health concern. Avian influenza strains such as H5N1 and H7N9 a e known to be extremely dangerous to human beings. A study led by St. Jude has found that a strain of the avian influenza A H3N8 virus, which killed more than 160 harbor seals in New England in 2011, also poses a threat to people. The findings reinforce the need for continued surveillance of flu viruses circulating among wild and domestic animals.
September 2014 Nature Communications |
Sun damage causes genetic changes that predispose children and adolescents to melanoma.
A study from the St. Jude Children’s Research Hospital-Washington University Pediatric Cancer Genome Project shows that conventional melanoma is essentially the same disease in children and adults. The findings could lead to better diagnosis an treatment of the disease.
March 2015 Journal of Investigative Dermatology |
Tracking defects caused by brain tumor mutationyields insight to advance targeted therapy
Scientists at St. Jude Children’s Research Hospital have made new progress in a long-term battle to beat the most common pediatric brain tumor, medulloblastoma. Building on previous St. Jude research discoveries, St. Jude scientists found that mutations of a certain gene linked to a subtype of medulloblastoma do not all lead to a single common cell defect. This means treatments targeting these mutations must be tailored for the specific defects.
May 2015 Journal of Molecular Biology
|
Finding cures. Saving children.® 2015 St. Jude Annual Report | Page 16
Inherited gene variations tied to treatment- related hearing loss in cancer patients
Scientists from St. Jude have found that hearing loss in some young cancer patients treated with cisplatin, a mainstay of cancer treatment, is associated with inherited genetic variations in those patients.
February 2015 | Nature Genetics
Chromosomal rearrangement is the key to progress against aggressive infant leukemia
A study from the St. Jude Children’s Research Hospital-Washington University Pediatric Cancer Genome Project offers insight into a very aggressive form of acute lymphoblastic leukemia (ALL) that strikes infants. The findings suggest that in most cases of the disease targeting a specific chromosome rearrangement may likely be the key to improved survival.
March 2015 | Nature Genetics
For more information about the groundbreaking medical and scientific work of St.Jude, please see the St. Jude Scientific Report a stjude.org/stjudepublications.
During the past five decades, St. Jude has made remarkable progress toward curing childhood cancer and other life-threatening diseases. But our work is not done.
St. Jude is striving to push cure rates ever higher, while developing tailored treatments to decrease side effects.
To do that, St. Jude plans to double the number of children enrolled in St. Jude-led clinical trials and will create a national referral clinic for rare pediatric cancers. In 2015, the hospital began treating patients in the only proton therapy center dedicated solely to children. St. Jude also began to perform an unparalleled level of DNA sequencing of patients’ tumor and normal cells through the Genomes for Kids clinical study.
St. Jude creates more clinical trials
for cancer than any other children’s hospital
MORE THAN THE NEXT TOP 9 INSTITUTIONS COMBINED
ST. JUDE IS LEADING EFFORTS
OF THE CHILDHOOD CANCER
SURVIVORS STUDY, ONE OF
THE WORLD’S LARGEST STUDIES
OF LONG-TERM CANCER EFFECTS
&
Finding cures. Saving children.® 2015 St. Jude Annual Report | Page 18
St. Jude Patient
Damienmedulloblastoma
Every year,
about 175,000 the majority of children will not have access to adequate
cases of cancer will be diagnosed in diagnosis & treatmentchildren around the world.
&
Finding cures. Saving children.® 2015 St. Jude Annual Report | Page 20
Our St. Jude global effort was created to help improve survival rates for children with cancer and other life-threatening diseases around the globe. Through the development of partner sites and regional networks, and our cure4kids.org website, we are working with health care professionals across the globe to help erase treatment disparities and improve care for children.
Learn more about the St. Jude international effort at stjude.org/international.
Page 22
St. Jude Patient
Leaacute myeloid leukemia
Finding cures. Saving children.® 2015 St. Jude Annual Report |
A Great CharityUnlike any other hospital, the majority of funding for St. Jude comes from generous donors.
Thanks to millions of people like you, families never receive a bill from St. Jude for treatment, travel, housing or food – because all a family should worry about is helping their child live.
YOUR DEDICATION TO OUR MISSION comes alive in the
31,000 activities
HELD THROUGHOUT THE COUNTRY EACH YEAR TO RAISE FUNDS & AWARENESS FOR ST. JUDE
Finding cures. Saving children.® 2015 St. Jude Annual Report | Page 24
IT WILL COST NEARLY
$ 1 billionTO OPERATE ST. JUDE
in 201675%more than of those fund
must be raiseby public contributions
s d
Finding cures. Saving children.® 2015 St. Jude Annual Report | Page 26
averageMORE
9 mTHAN
illion INDIVIDUAL DONATION
active donors $35THIS IS MADE POSSIBLE BY THE GENEROSITY OF
Finding cures. Saving children.® 2015 St. Jude Annual Report | Page 28
Meet Phoenixage 5 | retinoblastoma
“ Where would we be today if it weren’t for St. Jude? Lost,” says Pamela, with a sob in her voice.
Pamela’s grandson, 5-year-old Phoenix, became a St. Jude patient on Christmas Day 2012. At the time, he was only 17 months old. “We had noticed that he didn’t have full control of both his eyes. They weren’t always lined up,” Pamela recalls. “And we knew by age 1, he should have that control.”
Phoenix’s doctor back home referred him to St. Jude Children’s Research Hospital, where the terrifying diagnosis was confirmed: bilateral retinoblastoma – cancerous tumors in both eyes. At St. Jude, Phoenix underwent eleven months of chemotherapy.
Today, the cancer is in remission, and Phoenix returns to St. Jude regularly for checkups to make sure it stays that way. Like all St. Jude patients, Phoenix receives this care at no charge to his family. Families never receive a bill from St. Jude for treatment, travel, housing or food – because all a family should worry about is helping their child live.
Phoenix is a budding drummer who loves to sing and dance. “Physically he’s doing good. Emotionally he’s doing good,” says Pamela. “I know St. Jude is the reason he has both his eyes. I tell everyone everywhere I go, St. Jude is amazing. I know God has to be in the midst of it. I don’t think I would have my grandson if we had not gotten to St. Jude.”
Finding cures. Saving children.® 2015 St. Jude Annual Report | Page 30
Leadership & Service“ Those who work for the good are as those who do the good.”
—Arab proverb in Danny Thomas/ALSAC Pavilion
ALSAC/St. Jude Boards of Directors & Governors
Legacy of Service
The members of the ALSAC/St. Jude Boards of Directors and Governors are volunteers from throughout the United States who serve without compensation. Many represent the second and third generations of their families who have supported St. Jude through service on the Board. An honorary body of emeritus members recognizes distinguished service on the Board by those unable to continue to actively participate.
FY15 ALSAC Board of Directors Officers
Richard M. Unes Construction Chair
Paul J. AyoubAttorneyFirst Vice Chair
James B. Barkate Real Estate/Title Research Second Vice Chair
Frederick R. Harris Manufacturing Secretary
FY15 St. Jude Board of GovernorsOfficers
Terry L. BurmanBusinessChair
Martha Perine Beard Banking First Vice Chair
Camille F. Sarrouf Jr. Attorney Second Vice Chair
Fred P. Gattas Jr. Business Consultant Secretary
FY15 Members
Joyce A. Aboussie Public Relations
Salem A. Abraham Investments
Susan Mack Aguillard, MD Pediatrician
Mahir R. Awdeh, MD Cardiologist
Joseph S. Ayoub Jr. Consultant
Frederick M. Azar, MD Chief of Staff, Orthopedic Surgeon
José BarraMerchandising
Sheryl A. BouriskPublic Relations/Marketing
Robert A. Breit, MD Radiologist
Ann M. Danner Real Estate Developer
Fred P. Gattas III, PharmD Nuclear Pharmacist and Corporate Pharmacy Quality Manager
Ruth Gaviria Marketing
Christopher B. George, MD Physician – Oncology/Hematology
Judy A. Habib Marketing
Gabriel G. Haddad, MD Pediatrics Cancer Genes and Genome Program
Paul K. Hajar Publishing
Charles C. Hajjar Real Estate
Fouad M. Hajjar, MD Pediatric Hematology Oncology
Bruce B. Hopkins Banking
Michael D. McCoy Sheriff
Robert T. Molinet Securities and Corporate Law
Dwayne M. Murray Attorney
James O. Naifeh Jr. Business
Ramzi Nuwayhid Financial Advisor
Thomas J. Penn III NBA Administration
Camille F. Sarrouf Sr. Attorney
Joseph C. Shaker Advertising
Joseph G. Shaker Advertising
George A. Simon II Manufacturing
Michael C. Simon Investments
Paul J. Simon Manufacturing
Terre Thomas Writer
Tony Thomas Producer
Paul H. Wein Attorney
Thomas C. Wertz Finance
Tama Zaydon Investments
Emeritus Members (Non-voting members of the Board)
Thomas G. Abraham Media Production
Jack A. Belz Real Estate
Stephen J. Camer, MD Surgeon
V. Reo Campian Manufacturing
Joseph G. Cory, PhD Professor of Biochemistry
Leslie Dale Communications
Lewis R. Donelson III Attorney
Edward M. Eissey, PhD Educator
George Elias Jr. Attorney
Hasan M. Elkhatib Pharmaceuticals
Sam F. Hamra Attorney
Theodore Hazer Broker
Joseph G. Hyder Broadcasting
Finding cures. Saving children.® 2015 St. Jude Annual Report | Page 32
Joseph D. Karam Wendy’s Franchise Owner
Richard J. Karam Attorney
James A. Kinney Banking
Julia R. Lester Business
Salli E. LeVanMarketing
Donald G. Mack, MD Pediatrician
George M. Maloof Attorney
Paul J. Marcus Investments
James O. Naifeh Government
David B. Nimer Export-Import
Talat M. Othman Investments
Manal B. Saab Business
Frederick W. Smith Aviation Transportation
Ronald A. Terry Investments
Pat Kerr Tigrett Designer
Robert P. Younes, MD Physician
Ramzi T. Younis, MDPhysician
Ex-Officio Voting Members
Richard C. Shadyac Jr. President and CEO ALSAC/St. Jude
James R. Downing, MD President and CEOSt. Jude Children’s Research Hospital
Chief Governance Officer/ Corporate Secretary
Leah Domitrovic
Epsilon Sigma Alpha
Vicky Farris(Non-elected member)
Scientific Advisory BoardThe Scientific Advisory Board is an autonomous panel of renowned physicians and scientists who help foster the medical and scientific development of St.Jude, providing guidance and insight on research directions, clinical activities and institutional policy.
FY15 ChairMichael P. Link, MD The Lydia J. Lee Professor of PediatricsDivision of Hematology/Oncology Stanford University School of Medicine Lucille Packard Children’s Hospital Stanford
FY15 Vice ChairTheodore S. Lawrence, MD, PhD, FASTRO, FASCO Max S. Wicha, MD Distinguished Professor of OncologyDirector, University of Michigan Comprehensive Cancer CenterChair, Department of Radiation OncologyUniversity of Michigan Medical School
FY15 MembersAndrea Califano, PhD Clyde and Helen Wu Professor of Chemical and Systems Biology Chair, Department of Systems BiologyDirector, JP Sulzberger Columbia Genome CenterAssociate Director, Herbert Irving Comprehensive Cancer Center Columbia University
David S. Eisenberg, DPhil Howard Hughes Medical Institute InvestigatorPaul D. Boyer Professor of Biochemistry and Molecular BiologyUniversity of California at Los Angeles
Patricia A Ganz, MD Distinguished Professor of Health Policy and Management,UCLA Fielding School of Public HealthProfessor of Medicine, UCLA David Geffen School of MedicineDirector, Center for Cancer Prevention & Control Research, Jonsson Comprehensive Cancer CenterUniversity of California at Los Angeles
Todd Golub, MD – Chair Emeritus Howard Hughes Medical Institute InvestigatorChief Scientific Officer and Director, Cancer Program, Broad InstituteProfessor of Pediatrics, Harvard Medical School
David P. Harrington, PhD Professor of Biostatistics, Harvard T.H. Chan School of Public HealthProfessor, Biostatistics and Computational Biology, Dana-Farber Cancer Institute
Mignon L. Loh, MDProfessor of Clinical Pediatrics, Deborah and Arthur Ablin Endowed Chair in Pediatric Molecular OncologyDivision Chief, Hematology/Oncology University of California Benioff Children’s Hospital
Ellis J. Neufeld, MD, PhDAssociate Chief, Division of Hematology/OncologyDana-Farber/Boston Children’s Center for Cancer and Blood DisordersEgan Family Foundation Chair in Transitional Medicine, Harvard Medical School
Finding cures. Saving children.® 2015 St. Jude Annual Report | Page 34
Jennifer A. Pietenpol, PhDProfessor of Biochemistry, Cancer Biology and OtolaryngologyDirector, Vanderbilt-Ingram Cancer CenterBenjamin F. Byrd Jr. Endowed Chair in OncologyVanderbilt University School of Medicine
Raphael E. Pollock, MD, PhD, FACSProfessor and Director, Division of Surgical OncologyVice Chairman for Clinical Affairs, Department of SurgerySurgeon in Chief, James Comprehensive Cancer CenterSurgeon in Chief, The Ohio State University Health System
David H. Rowitch, MD, PhDProfessor of Pediatrics and Neurological Surgery and Chief of NeonatologyHoward Hughes Medical Institute InvestigatorUniversity of California at San Francisco
Michel Sadelain, MD, PhDDirector, Center for Cell EngineeringStephen and Barbara Friedman ChairMemorial Sloan Kettering Cancer Center
Fundraising & Awareness GuidanceThe volunteers who serve on the Professional Advisory Board and the ALSAC Leadership Board are leaders and experts in their fields who meet regularly to provide guidance to ALSAC on strategic fundraising issues and ways to raise awareness for the St. Jude mission.
FY15 Professional Advisory Board
Marty Belz Peabody Hotel Group
Scott Bowman Global Net Lease
Douglas H. Brooks Brinker International (retired)
Jeb Bush, Jr. Jeb Bush and Associates LLC
Kay Dempsey The Dempsey Companies
Joe DeVivo AngioDynamics Inc.
Michael Francis Farview Associates, LLC
Daisy Fuentes Model and TV Show Host
Don Germano Follett Corporation
Greg Gumbel Sportscaster
Richard Ieyoub Ieyoub Law Firm
George Joulwan U.S. Army General (retired)
J. David KaramSbarro Inc.
Erik Logan OWN, The Oprah Winfrey Network
Michael J. Lynch Bank of America Merrill Lynch
Maguy Maccario Doyle Ambassador of Monaco to the United States and Canada
T. Allan McArtor Airbus Group Inc.
Warren Moon Sports 1 Marketing
Marianne Silver Coyote Logistics LLC
Joe Theismann JRT Associates Inc.
Gary Tobey Haworth Marketing and Media
Eric Trump The Eric Trump Foundation
LuAnn Via Christopher & Banks Corporation
Russell Weiner Domino’s Pizza
Duncan Williams Duncan-Williams Inc.
Craig Witsoe Elo Touch Solutions
FY15 ALSAC Leadership Board
Richard A. Abdoo Wisconsin Energy Corporation (retired)
Marilyn Aboussie Chief Justice of the 3rd Court of Appeals, Texas (retired)
Amin J. Barakat, MD Clinical Professor of PediatricsGeorgetown University Medical Center
Finding cures. Saving children.® 2015 St. Jude Annual Report | Page 36
Joseph G. (Joe) Bisceglia Jenner & Block LLP
Romero Britto Artist, Britto Central
Nicholas Buttafuoco Buttafuoco, Arce & Price
Pamela Silva Conde Univision Network
Nick Caporella National Beverage Corp.
Terri Carr Wisteria Fashions
Jacqueline Corso Barnes & Noble
Robert ‘Bob’ Corliss Robert Talbott, Inc.CorlissMoore
Chaz Corzine The MWS Group
Trish Coury Gustafson Coldwell Banker Previews International
Joseph K. DeLapp II Visioneering Technologies Inc.
John M. Engquist H & E Equipment Services LLC
Charles A. Feghali NGE Systems LLC
Georgia Hobaica Frasch Philanthropist
Andrew Graves JPMorgan Chase Bank, NA
Marilena Greig Philanthropist & Volunteer
Robert Hureau Pharmaceutical Product Development Inc.
Eileen Hutton Brilliance Audio (retired)
Randa Fahmy Hudome Fahmy Hudome International LLC
Lawrence K. Jensen Commercial Advisors LLC
Linda Johansen-James American Kiosk Management LLC
Albert F. Johary, MD Internal Medicine
Margo R. Keyes Key Development LLC
Wes Kraker Pathmark Transportation
Martha Byrne McMahon Actress
Eunice Mazloom Philanthropist and Volunteer
Lattimore M. Michael Back Yard Burgers Inc. (retired)
William ‘Bill’ N. Morris Jr. The Morris Group
Jerry D. Neal RF Micro Devices (retired)
Scott Nietschmann Boloco Restaurants
William C. Perez Adams and Reese LLP
Nick J. Rahall U.S. House of Representatives
Thomas M. Rashid, MD Urology
Gary J. RotellaAttorney
Andrew San Marco Tradition
Jack Soden Elvis Presley Enterprises Inc.
Gary B. Stone Strategic Thinking One on One
John L. Strauss The John and Bonnie Strauss Foundation
Arnie J. Schwartzman Arent Fox LLP
John Tanner Prime Policy Group
Peter J. Tanous Lepercq Lynx Investment Advisory
Amber Valletta Model and Actress
Mac Winker Former owner and CEO of The Racquet Club of Memphis
St. Jude Executive CommitteeJames R. Downing, MDPresident and Chief Executive Officer
Mary Anna QuinnChief Administrative OfficerExecutive Vice President
Charles Roberts, MD, PhDCancer Center DirectorExecutive Vice President
Carlos Rodriquez-Galindo, MDInternational Outreach DirectorExecutive Vice President
Robyn Diaz, JDChief Legal OfficerSenior Vice President
Pam Dotson, RN, MBAChief Nursing OfficerSenior Vice President & Chief Nursing Officer
Keith PerryChief Information OfficerSenior Vice President
Pat KeelChief Financial OfficerSenior Vice President
Shari CapersVice President, Strategic Planning & Decision Support
Victor Santana, MDVice President of Clinical TrialsAssociate Director of Clinical Research
James Boyett, PhDChair, Biostatistics
Andrew Davidoff, MDChair, Surgery
David Ellison, MD, PhDChair, Pathology
Amar Gajjar, MDCo-chair, Oncology
Doug Green, PhDChair, Immunology
Gerard Grosveld, PhDChair, Genetics
Kip Guy, PhD Chair, Chemical Biology & Therapeutics
Thomas Merchant, DO, PhD Chair, Radiation Oncology
James Morgan, PhDChair, Developmental Neurobiology
Sean Phipps, PhDChair, Psychology
Ching-Hon Pui, MDChair, Oncology
Mary Relling, PharmDChair, Pharmaceutical Sciences
Les Robison, PhDChair, Epidemiology & Cancer Control
Charles Sherr, MD, PhDChair, Tumor Cell Biology
J. Paul Taylor, MD, PhDChair, Cell & Molecular Biology
Elaine Tuomanen, MDChair, Infectious Diseases
Weiss, Mitchell, MD, PhDChair, Hematology
Stephen White, DPhil Chair, Structural BiologyDean of the Graduate School
Jinghui Zhang, PhDChair, Computational Biology
Suzanne Baker, PhDDirector, Brain Tumor Research Division
Michael Dyer, PhD Director, Developmental Biology Division
Terrence Geiger, MD, PhDMedical Director, Clinical Pathology
Melissa Hudson, MDDirector, Cancer Survivorship Division
Matthew Krasin, MDDirector, Radiation Dosimetry Core
Alberto Pappo, MDDirector, Solid Tumor Division
Charles Mullighan, MBBS, MDCo-Leader, Hematological Malignancies Program
Martine Roussel, PhDCo-Leader, Cancer Genetics
Brenda Schulman, PhDCo-Leader, Cancer Genetics
Jonathan McCullers, MDAdjunct Faculty, Infectious Diseases
Finding cures. Saving children.® 2015 St. Jude Annual Report | Page 38
ALSACExecutive Leadership Team
Richard C. Shadyac Jr.President and Chief Executive Officer
Emily CallahanChief Marketing Officer
Emily S. GreerChief Administrative Officer
Sara HallChief Legal Officer
Martin HandChief Donor Officer
Sue HarpoleChief Development Officer
Robert MachenChief Information Officer
Anurag PanditChief Investment Officer
Jeffrey T. PearsonChief Financial Officer
George P. ShadrouiChief Strategy Officer
Senior Vice Presidents
Christopher BoysenField Operations
Wilfred BusbyCall Centers
Mark EdmiastonFitness & Endurance Programs
Steele FordStrategic Partnerships
Steven FroehlichNational Direct Marketing
Melanee HannockInnovation and Strategy
Diane HeymanHuman Resources
Mike SiegelBrand and Creative
Vice Presidents
Brenda AbshureExecutive Office Operations
Aimee HallInteractive Group
Betty MacDougallCEO Affairs and Executive Communications
Kelly SchulzCommunications
Regina WatsonGift Planning
St. Jude Patient
Devonmedulloblastoma
Finding cures. Saving children.® 2015 St. Jude Annual Report | Page 40
ALSAC/St. Jude Children’s Research Hospital
Combined Financial Highlights for Fiscal Year 2015
Revenues 2Years Ended
015June 30 (in thousands)
2014 Total Support $1,064,761 $983,614
105,577 97,421
85,347 80,938
27,994 390,644
16,172
1,299,851
33,961
1,586,578
Net Patient Service Revenue
Research Grants
Net Investment Income
Other
Total Revenues
Expenses
Program Expenses
Patient Care Services
Research
Education, Training & Community Support
Total Program Expenses
Fundraising
Administrative & General
Total Expenses
Gain (loss) on Disposal of Property & Equipment
Change in Net Assets
Beginning Net Assets
Ending Net Assets
367,779
339,671
82,503
789,953
188,275
125,278
1,103,506
(918)
195,427
3,559,817
3,755,244
317,682
323,357
81,265
722,304
166,560
108,537
997,401
(1,689)
587,488
2,972,329
3,559,817
St. Jude Patient
Tashacute lymphoblastic leukemia
Finding cures. Saving children.® 2015 St. Jude Annual Report | Page 42
There are great children’s hospitals. There are great research institutions. There are great charities.
St. Jude Children’s Research Hospital is all three.
St. Jude won’t stop looking for cures for cancer and other life-threatening diseases. St. Jude will share its research with the world so that children everywhere can benefit from these discoveries. And families will never pay St. Jude for anything. We cover the cost of treatment, travel, housing and food so that all a family has to worry about is helping their child live.
Your generosity and support makes this possible. Thank you for being a part of our mission.
Visit stjude.org today to find out how you can make a difference.
To view the interactive Finding cures. Saving children.® 2015 St. Jude Annual Report, visit the App Store and download the St. Jude Publications App on your iPad.
Finding cures. Saving children.® 2015 St. Jude Annual Report | Page 44
©2016 ALSAC/St. Jude Children’s Research Hospital (23742)